![Thermo Fisher's $12.5B deal for Qiagen falls through, as COVID-19 test demand lights new path forward | Fierce Biotech Thermo Fisher's $12.5B deal for Qiagen falls through, as COVID-19 test demand lights new path forward | Fierce Biotech](https://qtxasset.com/quartz/qcloud5/media/image/fiercebiotech/1597332040/24016516473_7a8c37ff83_b.jpg/24016516473_7a8c37ff83_b.jpg?VersionId=iQ8ylOC_G1uns9KqF4QqUvWmDaOrF1IN)
Thermo Fisher's $12.5B deal for Qiagen falls through, as COVID-19 test demand lights new path forward | Fierce Biotech
![QIAGEN on Twitter: "QIAGEN shareholders approve all agenda items related to acquisition by Thermo Fisher Scientific at Annual General Meeting. Full press release: https://t.co/R4wKLVyIrW https://t.co/Q4Dd8GpQFy" / Twitter QIAGEN on Twitter: "QIAGEN shareholders approve all agenda items related to acquisition by Thermo Fisher Scientific at Annual General Meeting. Full press release: https://t.co/R4wKLVyIrW https://t.co/Q4Dd8GpQFy" / Twitter](https://pbs.twimg.com/media/Ebx_OtFWsAEGmaa.jpg)
QIAGEN on Twitter: "QIAGEN shareholders approve all agenda items related to acquisition by Thermo Fisher Scientific at Annual General Meeting. Full press release: https://t.co/R4wKLVyIrW https://t.co/Q4Dd8GpQFy" / Twitter
![Thermo Fisher's M&A has been impressive, despite failure to close Qiagen acquisition - Boston Business Journal Thermo Fisher's M&A has been impressive, despite failure to close Qiagen acquisition - Boston Business Journal](https://media.bizj.us/view/img/6285091/marccasper*750xx524-699-38-0.jpg)
Thermo Fisher's M&A has been impressive, despite failure to close Qiagen acquisition - Boston Business Journal
![Evolution M&A Analysis: Evaluating Potential Acquisition Targets for Thermo Fisher Scientific - Evolution Search Partners Evolution M&A Analysis: Evaluating Potential Acquisition Targets for Thermo Fisher Scientific - Evolution Search Partners](https://evolutionexec.com/wp-content/uploads/2016/03/leading-image.jpg)